Clarke Neumann Biora Therapeutics, Inc. (BIOR) insider trading activity

Clarke Neumann is of BIORA THERAPEUTICS, INC.. Currently has a direct ownership of 465,564 shares of BIOR, which is worth approximately $777,491. The most recent transaction as insider was on Aug 15, 2024, when has been sold 26,629 shares (Common Stock) at a price of $0.67 per share, resulting in proceeds of $17,841. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 466K

0% 3M change

795.01% 12M change

Total Value Held $777,491

CLARKE NEUMANN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 15 2024	SELL Payment of exercise price or tax liability	$17,841 $0.67 p/Share	26,629 Reduced 5.41%	465,564 Common Stock
Feb 15 2024	BUY Grant, award, or other acquisition	-	230,000 Added 31.85%	492,193 Common Stock
Aug 15 2023	SELL Payment of exercise price or tax liability	$113,614 $3.14 p/Share	36,183 Reduced 41.02%	52,018 Common Stock
Aug 15 2023	BUY Grant, award, or other acquisition	-	210,175 Added 44.49%	262,193 Common Stock
May 15 2023	SELL Payment of exercise price or tax liability	$7,932 $3.35 p/Share	2,368 Reduced 2.61%	88,201 Common Stock
Mar 15 2023	SELL Payment of exercise price or tax liability	$27,348 $2.56 p/Share	10,683 Reduced 10.55%	90,569 Common Stock
Mar 15 2023	BUY Grant, award, or other acquisition	-	79,634 Added 44.02%	101,252 Common Stock
Feb 15 2023	SELL Payment of exercise price or tax liability	$290 $3.46 p/Share	84 Reduced 0.39%	21,618 Common Stock
Jan 03 2023	SELL Sale (or disposition) back to the issuer	-	44 Reduced 100.0%	0 Series X Preferred Stock
Nov 15 2022	SELL Payment of exercise price or tax liability	$1,222 $0.27 p/Share	4,529 Reduced 0.83%	542,398 Common Stock
Aug 15 2022	SELL Payment of exercise price or tax liability	$1,409 $1.04 p/Share	1,355 Reduced 0.25%	546,927 Common Stock
May 15 2022	SELL Payment of exercise price or tax liability	$6,229 $0.75 p/Share	8,305 Reduced 2.62%	308,320 Common Stock
May 15 2022	BUY Grant, award, or other acquisition	-	239,962 Added 30.44%	548,282 Common Stock
Apr 15 2022	BUY Grant, award, or other acquisition	-	184,843 Added 36.86%	316,625 Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$3,260 $1.9 p/Share	1,716 Reduced 1.29%	131,782 Common Stock
Nov 15 2021	SELL Payment of exercise price or tax liability	$2,609 $3.47 p/Share	752 Reduced 0.56%	133,498 Common Stock
Aug 15 2021	SELL Payment of exercise price or tax liability	$3,878 $1.66 p/Share	2,336 Reduced 1.71%	134,250 Common Stock
May 15 2021	SELL Payment of exercise price or tax liability	$3,552 $2.36 p/Share	1,505 Reduced 1.09%	136,586 Common Stock
Apr 15 2021	BUY Grant, award, or other acquisition	-	87,356 Added 38.75%	138,091 Common Stock
Mar 04 2021	SELL Payment of exercise price or tax liability	$6,334 $4.05 p/Share	1,564 Reduced 2.99%	50,735 Common Stock
Feb 15 2021	SELL Payment of exercise price or tax liability	$3,713 $5.6 p/Share	663 Reduced 1.25%	52,299 Common Stock
Dec 19 2020	SELL Payment of exercise price or tax liability	$10,908 $6.32 p/Share	1,726 Reduced 3.16%	52,962 Common Stock

Clarke Neumann

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIOR shares.

Notify only if

Value

Insider Trading

Get notified when an Biora Therapeutics, Inc. insider buys or sells BIOR shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIORA THERAPEUTICS, INC.

Track Activities on BIOR

Account